1428795-79-2

Upstream product

• 1428796-42-2 ethyl 9-hydroxy-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 4602-71-5 1-methyl-7-hydroxy-6-methoxy-3,4-dihydroisoquinoline 
• 1428796-43-3 ethyl 9-isopropoxy-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-54-6 ethyl 3-bromo-9-isopropoxy-8-methoxy-5,6-di hydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-55-7 3-bromo-9-isopropoxy-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylic acid 
• 1428796-56-8 (R)-3-bromo-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-9-isopropoxy-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1765-93-1 4-fluoroboronic acid 

Relevant academic research and scientific papers

FSH RECEPTOR ANTAGONISTS

The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders